Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, et al. Science 2020 Jun 15. pii: science.abc5902. doi: 10.1126/science.abc5902.

Read + Share

Amedeo Smart

Independent Medical Education

Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science 2020 Jun 15. pii: science.abc5902. doi: 10.1126/science.abc5902.
PMID: 32540902